86 web-programmer-developer "https:" "https:" "https:" "https:" "https:" "https:" positions at Nature Careers in United Kingdom
Sort by
Refine Your Search
-
lead and manage the School, maximising strategic opportunities arising from the changing landscape of higher education and the University’s strategic plan, whilst leading and delivering excellence in
-
aims to deliver world class regulation and improved outcomes for UK patients. We are currently looking for an experienced Principal Scientist (NMR) – Molecular Analysis to join our Research & Development
-
develop the foundational and scalable tools, technology and methods needed to synthesise large sections of human genomes/chromosomes. Through programmable synthesis of genetic material the aim is to unlock
-
development of novel technologies to study this problem. We are especially interested in growing our expertise in epitranscriptomics, RNA biology, single-cell/spatial approaches, microenvironment, and
-
in collaboration with AstraZeneca to develop next generation in vitro and ex vivo models of liver biology. The role involves working with bioengineers at the Francis Crick Institute to develop a novel
-
health and the economy. The Biological Research Facility supports all animal research at the Crick through our comprehensive animal care and use programme. The Biological Research Facility provides
-
-site higher education institutions. We operate at scale with an annual turnover of £1.35 billion, a significant ongoing capital investment programme, 12,800 staff and over 46,000 students from 190
-
We are looking for a highly motivated postdoctoral researcher to join the Dev Group at the University of Cambridge Early Cancer Institute. We are focused on developing sensitive, specific and
-
reshaping international collaboration. You will work closely with local teams, contribute to training and shared analytical development, and help steward a model that empowers researchers across the region
-
autoantibodies in autoimmune disease pathology, to reveal the underlying mechanisms by which anti-MICL autoantibodies mediate their pathological effects and develop approaches to block the effect